OTLK logo

Outlook Therapeutics (OTLK) Non Current Assets

Annual Non Current Assets

$1.32 M
+$314.10 K+31.18%

30 September 2023

OTLK Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$1.47 M
+$231.20 K+18.60%

30 June 2024

OTLK Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

OTLK Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-+11.6%
3 y3 years+1.4%+13.1%
5 y5 years-63.6%-59.4%

OTLK Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+31.2%at high+51.7%
5 y5 years-63.6%+31.2%-62.0%+51.7%
alltimeall time-93.3%+31.2%-93.0%+51.7%

Outlook Therapeutics Non Current Assets History

DateAnnualQuarterly
June 2024
-
$1.47 M(+18.6%)
Mar 2024
-
$1.24 M(-4.1%)
Dec 2023
-
$1.30 M(-1.9%)
Sept 2023
$30.98 M(+12.6%)
$1.32 M(-7.5%)
June 2023
-
$1.43 M(+47.0%)
Mar 2023
-
$971.90 K(-4.0%)
Dec 2022
-
$1.01 M(+0.5%)
Sept 2022
$27.52 M(+28.0%)
$1.01 M(-6.2%)
June 2022
-
$1.07 M(-5.7%)
Mar 2022
-
$1.14 M(-5.9%)
Dec 2021
-
$1.21 M(-7.1%)
Sept 2021
$21.51 M(+19.9%)
$1.30 M(+32.4%)
June 2021
-
$984.70 K(-25.3%)
Mar 2021
-
$1.32 M(-11.3%)
Dec 2020
-
$1.49 M(-16.9%)
Sept 2020
$17.94 M
$1.79 M(-10.9%)
June 2020
-
$2.01 M(-45.5%)
Mar 2020
-
$3.68 M(-5.1%)
DateAnnualQuarterly
Dec 2019
-
$3.88 M(+6.8%)
Sept 2019
$13.50 M(+308.8%)
$3.63 M(-74.8%)
June 2019
-
$14.40 M(-4.2%)
Mar 2019
-
$15.04 M(-8.3%)
Dec 2018
-
$16.40 M(-13.6%)
Sept 2018
$3.30 M(-15.4%)
$18.98 M(-9.4%)
June 2018
-
$20.95 M(+0.4%)
Mar 2018
-
$20.87 M(+23.3%)
Dec 2017
-
$16.93 M(+0.6%)
Sept 2017
$3.90 M(-31.2%)
$16.83 M(+5.6%)
June 2017
-
$15.94 M(-4.0%)
Mar 2017
-
$16.61 M(-3.9%)
Dec 2016
-
$17.27 M(-12.4%)
Sept 2016
$5.68 M(-62.6%)
$19.73 M(+8.8%)
June 2016
-
$18.13 M(-12.5%)
Mar 2016
-
$20.73 M(+0.6%)
Dec 2015
-
$20.60 M(+3.8%)
Sept 2015
$15.16 M(0.0%)
$19.84 M
Sept 2014
$15.16 M
-

FAQ

  • What is Outlook Therapeutics annual long term assets?
  • What is the all time high annual non current assets for Outlook Therapeutics?
  • What is Outlook Therapeutics quarterly long term assets?
  • What is the all time high quarterly non current assets for Outlook Therapeutics?
  • What is Outlook Therapeutics quarterly non current assets year-on-year change?

What is Outlook Therapeutics annual long term assets?

The current annual non current assets of OTLK is $1.32 M

What is the all time high annual non current assets for Outlook Therapeutics?

Outlook Therapeutics all-time high annual long term assets is $19.84 M

What is Outlook Therapeutics quarterly long term assets?

The current quarterly non current assets of OTLK is $1.47 M

What is the all time high quarterly non current assets for Outlook Therapeutics?

Outlook Therapeutics all-time high quarterly long term assets is $20.95 M

What is Outlook Therapeutics quarterly non current assets year-on-year change?

Over the past year, OTLK quarterly long term assets has changed by +$152.70 K (+11.56%)